How to Hire Regulatory Affairs Leaders for AI Medical Devices

How to Hire Regulatory Affairs Leaders for AI Medical Devices

An AI medical device can have excellent clinical performance and still never reach patients. Market access in Europe depends on a CE mark under the Medical Device Regulation, and increasingly on compliance with the EU AI Act as well. The person who makes that possible is the regulatory affairs leader, and for AI software the profile is very different from traditional MedTech.

In this article

1. Key takeaways
2. Why hiring regulatory affairs leaders for AI differs from traditional MedTech
3. Evaluating technical and regulatory competencies in SaMD profiles
4. Designing an elite Regulatory Affairs Director job description
5. Sourcing strategies for finding top regulatory AI talent in Europe
6. Regulatory affairs AI specialist compensation data (2026 benchmarks)
7. Why Optima Europe is the preferred headhunter for regulated digital health
8. Frequently asked questions
9. Conclusion

This guide explains what makes regulatory leadership for AI and Software as a Medical Device (SaMD) different, which competencies to test, how to structure the role, how to source candidates across Europe and what compensation to expect in 2026. It is written for CEOs, CTOs, founders, HR leaders and quality executives preparing for CE marking or expanding into new markets.

Key takeaways

• Regulatory leadership for AI medical devices requires software lifecycle expertise, not only traditional hardware compliance experience.
• Strong candidates know MDR software classification (Rule 11), IEC 62304, ISO 13485 and ISO 14971, and how the EU AI Act applies to AI medical devices.
• The ability to design change control for continuously improving models is one of the clearest differences between average and excellent candidates.
• Professionals with successful AI CE-marking experience are scarce in Europe and are usually reached only through direct, cross-border headhunting.

Why hiring regulatory affairs leaders for AI differs from traditional MedTech

Hiring a Regulatory Affairs Leader for AI medical devices requires looking beyond traditional hardware compliance backgrounds to find executives who can manage the rapid, iterative lifecycle of software development within static legal frameworks.

A regulatory affairs leader (AI) is a specialised compliance executive who designs and executes the strategy for securing and maintaining market clearance for artificial intelligence software applications under healthcare laws. In Europe, that work is anchored in the Medical Device Regulation (MDR), Regulation (EU) 2017/745, the legal framework governing the clinical evaluation, technical documentation and commercial sale of medical devices.

Two very different clocks

Traditional medical devices are developed over years, and a design is largely frozen before submission. AI software works on a different rhythm: engineering teams release updates in weeks, retrain models on new data and deploy through cloud infrastructure. The regulatory framework was not designed for that pace. Every meaningful change has to be assessed against the existing certification, and some changes require review by the Notified Body before release.

Why hardware experience is not enough

Many experienced regulatory managers built their careers on physical devices, where documentation follows a stable design and manufacturing process. AI products raise questions they may not have faced: how to document a model’s training data, how to classify cloud-based software, what counts as a significant change after retraining, and how to evidence cybersecurity and performance across software versions. Without that understanding, regulatory work becomes a bottleneck instead of a route to market.

Fluency in modern software development

The best candidates understand agile development, continuous integration and automated testing, and know how to connect them to regulatory documentation. They can work with engineering teams to make compliance part of the development pipeline, so that evidence is generated as the software is built rather than reconstructed before each audit.

Summary: AI medical devices change faster than the regulations that govern them. Regulatory leaders for this field need to understand software development, cloud architecture and model updates, and translate them into a compliant and defensible regulatory strategy.

Evaluating technical and regulatory competencies in SaMD profiles

A qualified AI Regulatory Affairs Leader must possess a comprehensive understanding of international software standards such as IEC 62304 alongside regional frameworks like the EU AI Act and Medical Device Regulation.

Core standards and frameworks

Candidates should demonstrate working knowledge of IEC 62304 (software lifecycle processes), ISO 13485 (quality management systems), ISO 14971 (risk management) and IEC 82304-1 (health software). For AI products, they also need to understand the EU AI Act. AI systems that are medical devices requiring third-party conformity assessment are classified as high-risk, and under the Digital Omnibus (Regulation (EU) 2026/1744) the high-risk obligations for AI embedded in regulated products apply from 2 August 2028. For a broader view of the Act’s timeline, see our guide on how the EU AI Act affects AI hiring tools in healthcare.

Classification under MDR Rule 11

Software classification is one of the best tests of real experience. Under MDR Rule 11, software that provides information used to make diagnostic or therapeutic decisions is generally Class IIa, rising to Class IIb where a decision could cause a serious deterioration of health or a surgical intervention, and to Class III where it could cause death or irreversible deterioration. Strong candidates can explain how intended purpose and claims drive classification, and how a small change in wording can move a product into a higher class with a very different regulatory pathway.

Change control for continuously learning models

A change control protocol is a documented engineering and regulatory procedure used to assess, log and approve software updates or algorithmic improvements without invalidating existing medical clearances. Ask candidates how they would handle a retrained model: which changes they would treat as significant, what evidence they would generate, when they would notify the Notified Body, and how they would align with the FDA’s Predetermined Change Control Plan (PCCP) approach for the US market. The EU AI Act also allows changes predetermined at the initial conformity assessment not to count as substantial modifications, which makes this planning skill even more valuable.

Track record with Notified Bodies

A Notified Body is an independent third-party organisation designated by an EU member state to assess the conformity of medical devices before they are placed on the European market. Look for candidates who have defended software performance data, clinical evaluation reports and risk files in front of Notified Body reviewers, and who can describe the questions they faced and how they resolved them.

Summary: Test candidates on four things: knowledge of software and quality standards, practical classification under Rule 11, the ability to design change control for evolving AI models, and proven experience defending submissions in front of Notified Bodies.

Designing an elite Regulatory Affairs Director job description

An effective job description for an AI Regulatory Affairs Director must balance strategic commercial vision with technical documentation ownership to ensure market entry pathways are clear from day one.

• Global Market Strategy: Mapping out and executing simultaneous or phased regulatory pathways for the EU (CE marking under MDR), the UK (MHRA) and the USA (FDA). This includes choosing the order of market entry, aligning claims and evidence across jurisdictions, and planning clinical evaluation so that data can support several submissions. The director should connect regulatory timelines directly to the company’s commercial and funding plans.
• Notified Body Management: Acting as the main interface with the Notified Body during conformity assessments, from selecting the body and planning the review to responding to non-conformities and preparing for audits. Notified Body capacity in Europe is limited, so early planning and a constructive working relationship can save months. The director owns the technical documentation strategy that supports CE marking for software.
• Post-Market Compliance Alignment: Working with MLOps, software and safety engineering teams to keep compliance records current as the product evolves. This covers post-market surveillance, vigilance reporting, change control, cybersecurity updates and performance monitoring. The goal is a system where every release is assessed and documented before deployment, without slowing the engineering team down unnecessarily.
• Cross-Functional Advocacy: Translating legal and regulatory requirements into practical development parameters for data scientists and software developers. This includes defining intended purpose, setting documentation standards for training data and model versions, and educating leadership and sales teams on what the product can and cannot claim. Clear communication prevents costly rework and misleading marketing.

Larger organisations may also want the director to act as the Person Responsible for Regulatory Compliance (PRRC) required under MDR Article 15, which requires specific qualifications and experience.

Summary: The strongest job descriptions combine four responsibilities: market access strategy across the EU, UK and US, Notified Body management, continuous post-market compliance, and translating regulation into engineering decisions.

Sourcing strategies for finding top regulatory AI talent in Europe

Because the pool of executives with successful AI CE-marking experience in Europe is very small, healthtech companies usually need direct, cross-border headhunting to source talent from competing digital health firms.

Stage 1: Target competitor mapping

The search begins by identifying companies across Europe with recently certified Class IIa or Class IIb SaMD products, as well as AI diagnostics and imaging companies preparing their first submissions. Regulatory leaders who have taken a product through MDR certification in the last few years are the core target group.

Stage 2: Value proposition tailoring

Experienced regulatory leaders are in demand and rarely looking. The opportunity needs to offer real influence: a seat at the leadership table, ownership of the regulatory strategy, clear equity or long-term incentives, and flexible or hybrid working. Candidates also want to see that the company understands regulation as a strategic function, not an administrative cost.

Stage 3: Technical literacy vetting

A multi-stage assessment should confirm that the candidate can discuss software version control, release processes, API and data structures, and model validation in enough depth to work credibly with engineers. Case-based questions, such as classifying a product or planning a model update, show far more than a review of past titles.

Stage 4: Strategic reference verification

References should focus on the candidate’s submission track record: which products they certified, how long reviews took, what non-conformities were raised and how they were resolved. Delays happen in every regulatory career. What matters is how the candidate managed them and what they learned.

Summary: Finding a regulatory leader for AI medical devices is a four-stage process: map companies with relevant certifications, build a compelling leadership offer, verify technical literacy, and check submission track records in detail.

Regulatory affairs AI specialist compensation data (2026 benchmarks)

Demand for digital health market access has pushed salaries for regulatory professionals with proven software experience above traditional MedTech regulatory roles across major European hubs.

Indicative base salary ranges for 2026:

• Regulatory Affairs Manager (SaMD): Germany €85,000 - €110,000, Netherlands €80,000 - €105,000, United Kingdom £75,000 - £95,000
• Senior Regulatory Director (AI/MDR): Germany €125,000 - €165,000, Netherlands €120,000 - €155,000, United Kingdom £110,000 - £145,000
• VP of Quality and Regulatory Affairs: Germany €170,000 - €220,000+, Netherlands €160,000 - €200,000+, United Kingdom £150,000 - £190,000+

Ranges are indicative and vary with company stage, product classification, scope of the role, equity and whether the position includes PRRC responsibility or line management of quality teams.

Summary: Regulatory professionals with SaMD and AI experience command a clear premium. The highest packages go to leaders who combine Notified Body experience, multi-market strategy and quality leadership.

Why Optima Europe is the preferred headhunter for regulated digital health

Optima Europe helps digital health companies shorten time to market by reaching regulatory leaders who have taken medical software through European certification. Since 2013, Optima has focused on a small number of specialist sectors, including digital health, MedTech and AI healthcare, with a candidate network of more than 33,000 professionals across the UK, Europe and North America.

• Focus on the convergence of technology and healthcare. We recruit across clinical, regulatory, commercial and technical functions, so we understand how regulatory leaders need to work with engineering and product teams.
• Cross-border search. We map and approach candidates across Europe’s key hubs, including Berlin, Munich, London, Amsterdam and the Nordics, rather than limiting a search to one country.
• Focused shortlists. Typically, around five carefully assessed candidates are presented per role, with no padded shortlists and no internal sales targets.

Summary: Optima combines sector focus, cross-border reach and a careful assessment process, helping AI medical device companies hire the regulatory leaders who make market access possible. For related leadership hires, see our guides on hiring Clinical AI Safety Officers and data privacy and GDPR compliance hiring.

Frequently asked questions

Can a traditional pharmaceutical regulatory manager pivot to handle AI medical software?

Yes, but it takes time and the right support. Pharmaceutical regulatory professionals bring strong skills in documentation, clinical evidence and working with authorities, but medical devices follow a different framework, with conformity assessment by Notified Bodies rather than marketing authorisation by medicines agencies. AI software adds further requirements, including IEC 62304, cybersecurity and change control for model updates. A pharma professional can succeed in a SaMD role if they receive device and software training and work alongside someone with device experience. For a company’s first senior regulatory hire, direct SaMD experience is usually the safer choice.

What is the average time-to-hire for a senior Regulatory Affairs Director in European healthtech?

Timelines depend on seniority, product classification, language requirements and location, but a senior Regulatory Affairs Director search in European healthtech often takes three to five months from briefing to start date. The search and selection phase typically takes eight to twelve weeks, and many senior candidates in Germany, the Netherlands and the UK have notice periods of three months or more. Starting with market mapping, a clear brief and an attractive leadership offer shortens the process. Companies with an upcoming Notified Body submission should start the search well ahead of their regulatory milestones.

How does the EU AI Act alter the workload of an MDR compliance manager?

The EU AI Act adds AI-specific requirements on top of MDR for AI systems that are medical devices requiring third-party conformity assessment. These include risk management for AI, data governance, technical documentation, logging, transparency and human oversight. Under the Digital Omnibus (Regulation (EU) 2026/1744), these high-risk obligations apply to AI embedded in regulated products from 2 August 2028. The two regimes are designed to work together, with a single conformity assessment and integrated documentation where possible, but compliance managers need to understand both and plan evidence that satisfies each.

Should our regulatory affairs leader report directly to the CTO or the CEO?

For most AI medical device companies, the senior regulatory leader should report to the CEO, or at least have direct access to the executive team. Regulatory strategy shapes product claims, market entry, funding timelines and commercial plans, so it is a business-level function, not only a technical one. Reporting to the CEO also protects independence when regulatory decisions conflict with engineering or sales priorities. The leader still needs a very close working relationship with the CTO, because most regulatory evidence for software is generated inside the development process.

Is it possible to utilize external consulting agencies instead of hiring a full-time regulatory head?

Yes, especially at an early stage. Regulatory consultancies can help with classification, gap analysis, technical documentation and submission preparation, and they bring experience from many projects. The limitation is continuity: AI software changes constantly, and post-market surveillance, change control and Notified Body relationships require someone inside the company who owns them every day. Many companies use consultants for specific projects and hire a full-time regulatory lead once they approach certification or commercial launch. The internal leader then manages consultants rather than relying on them for strategy.

Conclusion

An excellent AI algorithm has little commercial value until it is certified for clinical use. In Europe, that means navigating MDR, Notified Body reviews and the EU AI Act, while keeping pace with continuous software development. The regulatory affairs leader is the person who turns innovation into market access.

Because so few professionals have taken AI medical software through European certification, hiring the right leader requires a targeted, cross-border search. If you are planning your next regulatory hire, book a talent-mapping session with Optima’s AI healthcare recruitment team to see current candidate availability across Europe.

‍